The same study indicated that ACEis or ARRBs have multiple roles in inhibiting inflammation induced by the renin–angiotensin–aldosterone system axis, contributing to their beneficial effects on increasing survival rates in COVID-19 patients [27]. This evidence concerns the gene REN and COVID-19.